Actinogen Medical LimitedASX: ACW

Application for quotation of securities - ACW

Aug 4, 2026 at 10:43 PM EDT · Issued by Actinogen Medical Limited via ASX

Filed with ASX · Aug 4, 2026 at 10:43 PM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-acw-13

Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 1 / 7 Announcement Summary Entity name ACTINOGEN MEDICAL LIMITED Announcement Type New announcement Date of this announcement Wednesday August 05, 2026 The +securities to be quoted...

View Attachment

6ix hasn’t read this filing yet.

Actinogen Medical Limited on 6ix

In the deck

Actinogen Medical — Bioshares Biotech Summit 202617 slidesAug 6, 2026

Earlier from Actinogen Medical

ACW webinar on the future of Alzheimers treatmentAug 4
June 2026 Quarterly activity report & Appendix 4CJul 29
Xanamem depression trial published in British J PsychiatryJul 19
ACW third positive XanaMIA trial data committee reviewJun 17
Actinogen receives positive EMA scientific advice aligned with prior FDA guidance for its Alzheimer’s disease programMay 28

Later from Actinogen Medical

ACW Bioshares presentation, strong cortisol rationaleAug 5
Notification of cessation of securities - ACWAug 9
Updated Securities Trading PolicyAug 10
ACW webinar today, The future of Alzheimers treatmentAug 11
Appendix 3Y-Malcolm McComasAug 17

All Actinogen Medical news releases

Follow Actinogen Medical into a list and get an email when it puts out news.

Follow Actinogen Medical